Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon May 25, 2023 11:19am
238 Views
Post# 35463804

RE:SP price Prediction

RE:SP price Prediction

I agree: fastrack check your inbox.
I agree, today could become a huge new opportunity.
Akin to a whole new book in a series. Not even a new chapter, but whole new book.
Mangement has been talking this up big time & with significant confidence.
TODAY reminds me of watching the ball spin on a roulette wheel.
We know it will stop & reveal roughly 5 pm today.
Assume for a moment the wheel has only red or black.
Good news today will show continued upside tomorrow & onward.
Bad news & Fiday will be a sell- off.
After many years, it has now come down to hours.
Even that light, good or bad. Today is only the beginning.
Still need to negotiate a phase 3 partnership. 

Also need the Pancreatic Cancer, additional results.
Not to mention the whole Goblet G.I. Cancer trial program with Roche.
and the CAR-T , abstract also coming out this week. At ASCO 
Some of the day traders are happily taking profits today.
volume does not indicate a massive sell- off.
As a trading stock? Being up well over 60% since the recent low.
That will certainly invite profit taking.
watch for near end of day support.
THAT has historically been a great indicator of insider knowledge.
All the best , to everyone, regardless of your decision.
it truly is one of those times when you could see a double in a few trading days.
 

<< Previous
Bullboard Posts
Next >>